FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 76866 - Advisory Council on Alzheimer's Research, Care, and Services - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	Advisory Council on Alzheimer's Research, Care, and Services	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	76866
Original Establishment Date	5/23/2011	Committee Status	Chartered
Actual Termination Date		Committee URL	https://aspe.hhs.gov/collaborations-committees-...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	22
Terminated This FY	No	Designated Fed Officer Position Title*	DFO
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	8/10/2023	Designated Federal Officer First Name*	Helen
Date Of Renewal Charter	8/10/2025	Designated Federal Officer Middle Name
Projected Termination Date	12/31/2025	Designated Federal Officer Last Name*	Lamont
Exempt From Renewal*	No	Designated Federal Officer Suffix	PhD
Specific Termination Authority		Designated Federal Officer Phone*	(202) 260-6075
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Fax*
Specific Establishment Authority*	Public Law 111-375 (42 U.S.C. 11225), the National Alzheimer’s Project Act	Designated Federal Officer Email*	helen.lamont@hhs.gov
Effective Date Of Authority*	1/4/2011
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Other Committee

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The Advisory Council on Alzheimer’s Research, Care, and Services meets quarterly to discuss programs that impact people with Alzheimer’s disease and related dementias and their caregivers. The Advisory Council shall make recommendations about ways to reduce the financial impact of Alzheimer’s disease and related dementias and to improve the health outcomes of people with these conditions. The Advisory Council shall provide feedback on a National Plan for Alzheimer’s disease. On an annual basis, the Advisory Council shall evaluate the implementation of the recommendations through an updated national plan.
How is membership balanced?*	The Advisory Council shall consist of at least 10 Federal members including designees from the Centers for Disease Control and Prevention, Administration on Aging, Centers for Medicare and Medicaid Services, Indian Health Service, Office of the Director of the National Institutes of Health, National Science Foundation, Department of Veterans Affairs, Food and Drug Administration, Agency for Healthcare Research and Quality, and the Surgeon General. The Advisory Council shall also consist of 12 non-federal members selected by the Secretary or designee who are Alzheimer’s patient advocates, one of whom is living with dementia (2), Alzheimer’s caregivers (2), health care providers (2), representatives of State health departments (2), researchers with Alzheimer’s-related expertise in basic, translational, clinical, or drug development science (2), and voluntary health association representatives (2). The Secretary, or designee, shall appoint one of the members to serve as the Chair. In order to ensure reasonable continuity of membership, half of the initial members shall be invited to serve 2 year terms and half of the initial members shall be invited to serve 4 year terms. After the first two years, members shall be invited to serve for overlapping 4 year terms, except that any member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term. A member may serve after the expiration of the member’s term until a successor has taken office. Non-federal members will serve as Special Government Employees.
How frequent & relevant are cmte mtgs?*	The Advisory Council meets four times a year to discuss progress made on dementia research, care, and services. The Council also uses these quarterly meetings to discuss and create recommendations, which are sent to the Secretary of Health and Human Services and to Congress for possible action. The quarterly meetings allow the Council to have enough time to consider and evaluate progress and programs on dementia around the country. Meetings also have themes, where experts are invited to provide insight into less well-known issues around dementia, and to help the Council focus in on gaps in information and research.
Why advice can't be obtained elsewhere?*	The Committee is required by Public Law 111-375 (42 U.S.C. 11225), the National Alzheimer’s Project Act.
Why close or partially close meetings?	Not applicable- all meetings are open.
Recommendation Remarks	In FY2024, this Advisory Committee released the following recommendations: https://aspe.hhs.gov/sites/default/files/documents/ee9ec0fc1b37cd8064d9f6cc9013e80c/napa-2024-public-member-recommendations.pdf Please note that these recommendations were made and adopted during the 8/5/2924 meeting. The Advisory Committee also provided input on the 2024 Update to the National Plan to Address Alzheimer's Disease, which will be available at https://aspe.hhs.gov/reports/national-plan-2024-update in December 2024.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	Yes
Outcome Trust In Government	No	Action Reallocate Resources	Yes
Outcome Major Policy Changes	Yes	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	Yes
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	Yes	Action Comment	Not Applicable
Outcome Implement Laws/Reg Requirements	Yes	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	Not Applicable	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NA	Grants Review Comment	Not Applicable
Number Of Recommendations*	285	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	The recommendations are made to the Secretary of HHS, other federal agencies, Congress, states and healthcare providers. We only track the implementation of recommendations made to HHS and other federal agencies.	Access Agency Website	Yes
% of Recs Fully Implemented*	25.26%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	72/285	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	50.18%	Access Publications	Yes
% of Recs Partially Implemented Comment	143/285	Access Other	No
Agency Feedback*	Yes	Access Comment	http://aspe.hhs.gov/national-alzheimers-project-act
Agency Feedback Comment*	Federal agencies provide feedback and responses to recommendations during the public meetings of the Advisory Council. Recommendation that are implemented are reflected in the annual update to the National Plan to Address Alzheimer's Disease, which is publicly released every year before December 31.	Narrative Description*	The Advisory Council on Alzheimer's Research, Care, and Services consists of 22 members who meet quarterly to discuss the efficacy of government programs targeting the needs of individuals and caregivers coping with the consequences of Alzheimer's disease and related dementias. On an annual basis, the Advisory Council makes recommendations to the Secretary of HHS and to Congress. To the extent possible, these recommendations are incorporated into the annually-updated National Plan to Address Alzheimer's Disease.

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:57 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Government Federal Government Health Aging Public Health Medicine Diseases Health and Health Research Illnesses

Custom Links

Committee Level Reports